For 2023, an extended theme ‘Uniting our voices and taking action’ exhorts that meaningful steps must be taken to reduce cancer incidence and make early diagnosis more accessible. Bearing the theme in mind, BioSpectrum India connected with Raja Sekhar Kommu, Co-Founder and CTO, Karkinos Healthcare, whose company is leveraging new-age technologies to take evidence-based action in democratising cancer care. Edited excerpts;
The 2020 International Agency for Research on Cancer (IARC) GLOBOCAN’s cancer statistics reports that there were an estimated 19.3 million new cases of cancer and almost 10 million deaths from cancer. How can intervention by new age technologies make a difference to these numbers?
We have to pay attention to both the numbers here - number of new cases and number of deaths. The reason for such alarming numbers is because of the lack of awareness about cancer, lack of accessibility of cancer care and poor affordability of treatment. In most cases, cancer gets detected in the late stage making it very difficult for oncologists to save lives.
Technology, therefore, has a significant role to play to improve both the numbers. With the help of technology, one can leverage existing distribution networks to increase the awareness about cancer, thereby nudging the population to go for periodic checks for assessing their individual risk for common cancers. In addition, with advances in technologies the diagnosis for cancer is moving from invasive to non-invasive techniques such as liquid biopsy. It is possible to screen and diagnose large populations at a fraction of cost. Both these result in improving the overall new cases and helps move the needle from illness construct to wellness construct.
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.